$0.12
Galera Therapeutics is a biotechnology business based in the US. Galera Therapeutics shares (GRTX) are listed on the NASDAQ and all prices are listed in US Dollars. Galera Therapeutics employs 7 staff and has a market cap (total outstanding shares value) of 0.00.
Our top picks for where to buy Galera Therapeutics stock
How to buy Galera Therapeutics stock
- Choose a stock trading platform. Use our comparison table
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – GRTX. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
Buy Galera Therapeutics stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Galera Therapeutics stock price (NASDAQ: GRTX)
Use our graph to track the performance of GRTX stocks over time.Galera Therapeutics shares at a glance
Latest market close | $0.13 |
---|---|
52-week range | $0.07 - $2.74 |
50-day moving average | $0.14 |
200-day moving average | $0.17 |
Wall St. target price | $0.50 |
PE ratio | N/A |
Dividend yield | N/A (0%) |
Earnings per share (TTM) | $-0.91 |
Is it a good time to buy Galera Therapeutics stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Galera Therapeutics price performance over time
Historical closes compared with the close of $0.125 from 2024-07-25
1 week (2024-07-19) | -3.10% |
---|---|
1 month (2024-06-27) | -7.41% |
3 months (2024-04-26) | -32.83% |
6 months (2024-01-26) | -29.58% |
1 year (2023-07-27) | -94.73% |
---|---|
2 years (2022-07-27) | -89.30% |
3 years (2021-07-27) | 8.94 |
5 years (2019-07-23) | N/A |
Galera Therapeutics financials
Gross profit TTM | $0 |
---|---|
Return on assets TTM | -59.29% |
Return on equity TTM | -1063.11% |
Profit margin | 0% |
Book value | $-2.48 |
Market Capitalization | $7 million |
TTM: trailing 12 months
Galera Therapeutics share dividends
We're not expecting Galera Therapeutics to pay a dividend over the next 12 months.
Galera Therapeutics share price volatility
Over the last 12 months, Galera Therapeutics's shares have ranged in value from as little as $0.065 up to $2.74. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Galera Therapeutics's is 1.979. This would suggest that Galera Therapeutics's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Galera Therapeutics overview
Galera Therapeutics, Inc. , a biopharmaceutical company, focuses on the development and commercialization of therapeutics for the transformation of radiotherapy in cancer. The company's lead product candidate is avasopasem manganese (GC4419), a small molecule dismutase mimetic for the treatment of radiotherapy induced severe oral mucositis in patients with head and neck cancer (HNC); for the treatment of radiotherapy-induced esophagitis in patients with lung cancer; and for patients with HNC undergoing standard-of-care radiotherapy. It also develops rucosopasem manganese (rucosopasem) to augment the anti-cancer efficacy of stereotactic body radiation therapy in patients with non-small cell lung cancer and locally advanced pancreatic cancer. The company was incorporated in 2012 and is based in Malvern, Pennsylvania. .
Frequently asked questions
nullWhat percentage of Galera Therapeutics is owned by insiders or institutions?
Currently 36.153% of Galera Therapeutics shares are held by insiders and 18.768% by institutions. How many people work for Galera Therapeutics?
Latest data suggests 7 work at Galera Therapeutics. When does the fiscal year end for Galera Therapeutics?
Galera Therapeutics's fiscal year ends in December. Where is Galera Therapeutics based?
Galera Therapeutics's address is: P.O. Box 134, Malvern, PA, United States, 19355 What is Galera Therapeutics's ISIN number?
Galera Therapeutics's international securities identification number is: US36338D1081 What is Galera Therapeutics's CUSIP number?
Galera Therapeutics's Committee on Uniform Securities Identification Procedures number is: 36338D108
More guides on Finder
-
Opto review 2024: $0 commission, fractional theme investing
Trade commission-free stocks and ETFs with Opto, and stay ahead by spotting emerging trends through thematic investing.
-
Best paper trading platforms to practice trading with fake money [2024]
Check out our picks of the best paper trading platforms to practice trading and investing with fake money.
-
Put options explained
Learn the basics of put options: what they are, how they work and a few examples.
-
Best broker cash sweep rates for July 2024
Check out our picks for the brokers with the best cash sweep rates on uninvested cash.
-
7 best day trading platforms of July 2024
These are the best day trading platforms, according to Finder’s comprehensive analysis.
-
Today’s best brokerage account bonuses [Signup and transfer promos]
Explore the best bonuses for opening a new brokerage account.
-
11 apps like Webull you need to consider
Looking for a discount broker like Webull that offers something different? Here are some of the top alternatives to consider.
-
How to invest in the S&P 500 in 2024
What you need to know about investing in the leading indicator for the overall US stock market.
-
7 best ways to invest $10K
Check out our 7 ideas for how to invest $10K to maximize your money.
-
5 best ETFs for 2024
Check out the best-performing ETFs so far in 2024.
Ask a question